GEVOGevo, Inc.
$1.16-51% 1Y
$1.16
$1.1252 weeks$2.78
Is the price fair?
What GEVO's price assumes
Gevo, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.00× revenue.
2.00
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.30
Price / book · as of 2026-Q2
- EV / sales
- 2.62
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.30
- EV / EBIToperating margin −103%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 2.62
- Market capitalisation247.2 million shares, counted Aug 5, 2026
- $287M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #33 of 33 by RyuScore